These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32358213)

  • 1. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescents.
    Trent M; Gordon CM
    Pediatrics; 2020 May; 145(Suppl 2):S210-S218. PubMed ID: 32358213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood.
    Simon SL; Phimphasone-Brady P; McKenney KM; Gulley LD; Bonny AE; Moore JM; Torres-Zegarra C; Cree MG
    Lancet Child Adolesc Health; 2024 Jun; 8(6):443-455. PubMed ID: 38552655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadening the Scope of Polycystic Ovary Syndrome (PCOS) Care: Insights from the 2023 International Evidence-Based PCOS Guideline.
    Tay CT; Khomami MB
    Semin Reprod Med; 2023 Mar; 41(1-02):3-4. PubMed ID: 38113881
    [No Abstract]   [Full Text] [Related]  

  • 4. Bridging the Information Gap in Polycystic Ovary Syndrome: A Narrative Review with Systematic Approach.
    Tay CT; Williams F; Mousa A; Teede H; Burgert TS
    Semin Reprod Med; 2023 Mar; 41(1-02):12-19. PubMed ID: 38052244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Theoretically Grounded Exploration of Individual and Family Self-Management of Polycystic Ovary Syndrome in Adolescents.
    Young CC; Sagna AO; Monge M; Rew L
    Compr Child Adolesc Nurs; 2020 Dec; 43(4):348-362. PubMed ID: 31644327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New update of the international PCOS guideline-Focus on evidence-based medicine in the treatment of PCOS.
    Forslund M; Melin J; Piltonen T;
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1682. PubMed ID: 38923505
    [No Abstract]   [Full Text] [Related]  

  • 7. Mental health disorders-should we screen all our patients?
    Dokras A
    Fertil Steril; 2024 Mar; 121(3):368-369. PubMed ID: 38246402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does a compromised placenta contribute to transgenerational transmission of metabolic dysfunction in polycystic ovary syndrome?
    Abbott DH
    Fertil Steril; 2020 Jun; 113(6):1165-1166. PubMed ID: 32387276
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and management of polycystic ovarian syndrome.
    Dason ES; Koshkina O; Chan C; Sobel M
    CMAJ; 2024 Jan; 196(3):E85-E94. PubMed ID: 38286488
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of evidence-based diagnostic criteria in adolescents with polycystic ovary syndrome.
    Teede HJ; Neven ACH; Pena A
    Hum Reprod; 2024 May; 39(5):876-877. PubMed ID: 38514447
    [No Abstract]   [Full Text] [Related]  

  • 11. Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management.
    Kostopoulou E; Anagnostis P; Bosdou JK; Spiliotis BE; Goulis DG
    Curr Obes Rep; 2020 Sep; 9(3):193-203. PubMed ID: 32504286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
    Dewailly D; Barbotin AL; Dumont A; Catteau-Jonard S; Robin G
    Front Endocrinol (Lausanne); 2020; 11():641. PubMed ID: 33013710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
    Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
    Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management.
    Moran LJ; Tassone EC; Boyle J; Brennan L; Harrison CL; Hirschberg AL; Lim S; Marsh K; Misso ML; Redman L; Thondan M; Wijeyaratne C; Garad R; Stepto NK; Teede HJ
    Obes Rev; 2020 Oct; 21(10):e13046. PubMed ID: 32452622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic Ovary Syndrome: Ontogeny in Adolescence.
    Burt Solorzano CM; McCartney CR
    Endocrinol Metab Clin North Am; 2021 Mar; 50(1):25-42. PubMed ID: 33518184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the diagnosis of polycystic ovary syndrome.
    Rao P; Bhide P
    Ther Adv Reprod Health; 2020; 14():2633494120913032. PubMed ID: 32656532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of polycystic ovary syndrome pathogenesis.
    Rosenfield RL
    Curr Opin Pediatr; 2020 Oct; 32(5):698-706. PubMed ID: 32889963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes.
    Fitzgerald S; Stamoulis C; Gooding HC; DiVasta AD
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):697-702. PubMed ID: 32889085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome and aging: Health implications after menopause.
    Helvaci N; Yildiz BO
    Maturitas; 2020 Sep; 139():12-19. PubMed ID: 32747035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome.
    Abdalla MA; Deshmukh H; Atkin S; Sathyapalan T
    Ther Adv Endocrinol Metab; 2020; 11():2042018820938305. PubMed ID: 32670541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.